Published in Radiology on August 11, 2008
Perfusion magnetic resonance imaging of the liver. World J Gastroenterol (2010) 1.40
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Eur Radiol (2011) 1.02
Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma. J Magn Reson Imaging (2010) 0.94
CT perfusion of the liver: principles and applications in oncology. Radiology (2014) 0.92
DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility. J Magn Reson Imaging (2013) 0.88
Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI. AJR Am J Roentgenol (2013) 0.88
Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling. Eur Radiol (2009) 0.83
Multiparametric MR Imaging in Abdominal Malignancies. Magn Reson Imaging Clin N Am (2016) 0.83
Quantitative evaluation of dual-flip-angle T1 mapping on DCE-MRI kinetic parameter estimation in head and neck. Quant Imaging Med Surg (2012) 0.83
Rapid volumetric t1 mapping of the abdomen using three-dimensional through-time spiral GRAPPA. Magn Reson Med (2015) 0.77
Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study. Eur Radiol (2015) 0.77
Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI. MAGMA (2011) 0.77
The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data. Magn Reson Imaging (2014) 0.76
Three-dimensional whole-liver perfusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases. BMC Gastroenterol (2013) 0.76
Free-breathing liver perfusion imaging using 3-dimensional through-time spiral generalized autocalibrating partially parallel acquisition acceleration. Invest Radiol (2015) 0.76
GPU-accelerated voxelwise hepatic perfusion quantification. Phys Med Biol (2012) 0.75
Feasibility of Single-Input Tracer Kinetic Modeling with Continuous-Time Formalism in Liver 4-Phase Dynamic Contrast-Enhanced CT. Abdom Imaging (2014) (2014) 0.75
Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI. Sci Rep (2017) 0.75
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. Lancet Oncol (2010) 3.75
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Hepatol (2008) 1.87
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. J Clin Endocrinol Metab (2012) 1.80
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Clin Cancer Res (2008) 1.57
Differential diagnosis of jugular foramen lesions. Skull Base (2009) 1.52
Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med (2010) 1.48
Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies. J Clin Oncol (2009) 1.46
Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol (2010) 1.30
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Cell Mol Med (2009) 1.30
Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol (2011) 1.28
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. Int J Hepatol (2011) 1.24
Solid pseudopapillary tumour of the pancreas. ANZ J Surg (2003) 1.19
Intensity-modulated microbend fiber optic sensor for respiratory monitoring and gating during MRI. IEEE Trans Biomed Eng (2013) 1.13
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). J Hepatol (2009) 1.12
Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci (2007) 1.09
Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients. Pharmacogenet Genomics (2006) 1.08
Familial nasopharyngeal carcinoma in a cohort of 200 patients. Arch Otolaryngol Head Neck Surg (2006) 1.07
A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma. PLoS One (2012) 1.06
Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose. Clin Pharmacol Ther (2004) 1.05
Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination. Cancer (2005) 1.05
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells. Invest New Drugs (2007) 1.04
Eight-year experience with cryopreserved arterial homografts for the in situ reconstruction of abdominal aortic infections. J Vasc Surg (2010) 1.01
Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model. PLoS One (2008) 1.01
Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI. J Magn Reson Imaging (2011) 0.99
Functional characterization of novel allelic variants of CYP2C9 recently discovered in southeast Asians. J Pharmacol Exp Ther (2005) 0.98
18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen. Neuroradiology (2009) 0.98
DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97
Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope (2004) 0.96
Lipoma of the pancreas, a case report and a review of the literature. World J Radiol (2011) 0.96
Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines. J Cancer Res Clin Oncol (2008) 0.94
A Phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinoma. Clin Cancer Res (2011) 0.93
AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer. Mol Cancer Ther (2009) 0.93
Detection of epidermal growth factor receptor variations by partially denaturing HPLC. Clin Chem (2006) 0.92
Optimum slicing of radical prostatectomy specimens for correlation between histopathology and medical images. Int J Comput Assist Radiol Surg (2010) 0.91
The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity. Blood (2011) 0.91
Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response. Radiology (2012) 0.90
Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease. Acad Radiol (2013) 0.90
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients. Lung Cancer (2008) 0.89
Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. J Clin Oncol (2009) 0.88
Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany. Mol Imaging Biol (2014) 0.88
A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Radiol (2008) 0.88
Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis. Phys Med Biol (2007) 0.88
Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them? NMR Biomed (2014) 0.87
Craniofacial reconstructions with bone-anchored epithesis in head and neck cancer patients--a valid way back to self-perception and social reintegration. Anticancer Res (2008) 0.87
VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer. Mol Cancer Ther (2012) 0.86
High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke: possible involvement of hydrogen sulfide. J Neuropathol Exp Neurol (2006) 0.85
Cervical lymph nodes. Eur J Radiol (2008) 0.85
Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione. Int J Biochem Cell Biol (2004) 0.85
Independent component analysis of dynamic contrast-enhanced magnetic resonance images of breast carcinoma: a feasibility study. J Magn Reson Imaging (2008) 0.85
Primary cerebral low-grade B-cell lymphoma, monoclonal immunoglobulin deposition disease, cerebral light chain deposition disease and "aggregoma": an update on classification and diagnosis. BMC Neurol (2013) 0.85
Intraoperative visualization of residual tumor: the role of perfusion-weighted imaging in a high-field intraoperative magnetic resonance scanner. Neurosurgery (2013) 0.84
Effect of bortezomib and cetuximab in EGF-stimulated HNSCC. Anticancer Res (2008) 0.84
Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling. Eur Radiol (2009) 0.83
Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.83
Population pharmacokinetics of modafinil and its acid and sulfone metabolites in Chinese males. Ther Drug Monit (2011) 0.82
Primary colorectal cancer: use of kinetic modeling of dynamic contrast-enhanced CT data to predict clinical outcome. Radiology (2013) 0.81
Early neurologic outcome after bovine pericardium versus venous patch angioplasty in 599 patients undergoing carotid endarterectomy. Vascular (2010) 0.81
Exon sequencing and association analysis of EPHX1 genetic variants with maintenance warfarin dose in a multiethnic Asian population. Pharmacogenet Genomics (2011) 0.81
Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI. Acta Radiol (2012) 0.81
Lymph node staging. Top Magn Reson Imaging (2007) 0.80
Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. Antioxid Redox Signal (2013) 0.80
Novel agents that potentially inhibit irinotecan-induced diarrhea. Curr Med Chem (2005) 0.79
Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Head Neck (2004) 0.79
In vivo proton magnetic resonance spectroscopic imaging of the healthy human brain at 9.4 T: initial experience. MAGMA (2014) 0.79
Local experience of endorectal magnetic resonance imaging of prostate with correlation to radical prostatectomy specimens. Ann Acad Med Singapore (2008) 0.79
A case of Sweet's syndrome due to 5-Azacytidine and vorinostat in a patient with NK/T cell lymphoma. Cutan Ocul Toxicol (2011) 0.79
Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat. J Pharm Biomed Anal (2005) 0.79
Low-grade Glioma Surgery in Intraoperative Magnetic Resonance Imaging: Results of a Multicenter Retrospective Assessment of the German Study Group for Intraoperative Magnetic Resonance Imaging. Neurosurgery (2016) 0.78
Hepatocellular carcinoma masquerading as a bleeding gastric ulcer: a case report and a review of the surgical management. World J Gastroenterol (2007) 0.78
A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy. NMR Biomed (2011) 0.78
Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas. J Neurooncol (2014) 0.78
Computed tomography assessment of cerebral perfusion using a distributed parameter tracer kinetics model: validation with H(2)((15))O positron emission tomography measurements and initial clinical experience in patients with acute stroke. J Cereb Blood Flow Metab (2007) 0.78
Portal vein thrombosis secondary to hyperhomocysteinemia: a case report. Dig Dis Sci (2006) 0.78
Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy. Head Neck (2007) 0.78
Dynamic contrast-enhanced computed tomography in metastatic nasopharyngeal carcinoma: reproducibility analysis and observer variability of the distributed parameter model. Invest Radiol (2012) 0.77
Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients. Br J Clin Pharmacol (2003) 0.77
Diffusion tensor imaging in a human PET/MR hybrid system. Invest Radiol (2010) 0.77
Unilateral breast edema in two patients with malignant pleural effusion. Tumori (2005) 0.77
Role of computed tomography imaging in predicting response of nasopharyngeal carcinoma to definitive radiation therapy. Laryngoscope (2006) 0.77
Atypical enhancement pattern of hepatocellular carcinoma with portal vein thrombosis on multiphasic CT. Ann Acad Med Singapore (2011) 0.77
Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results. Clin Physiol Funct Imaging (2009) 0.77
Temporal bone changes in patients with Goldenhar syndrome with special emphasis on inner ear abnormalities. Otol Neurotol (2014) 0.77
Simultaneous subependymomas in monozygotic female twins: further evidence for a common genetic or developmental disorder background. J Neurosurg (2014) 0.76
Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2004) 0.76
Vascular parkinsonism in moyamoya: microvascular biopsy and imaging correlates. Ann Neurol (2003) 0.76
Spectroscopy imaging in intraoperative MR suite: tissue characterization and optimization of tumor resection. Int J Comput Assist Radiol Surg (2013) 0.76
Patient comfort during positron emission tomography/magnetic resonance and positron emission tomography/computed tomography examinations: subjective assessments with visual analog scales. Invest Radiol (2015) 0.76
Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results? Anticancer Res (2007) 0.75